January 24, 2025
SAN ANTONIO — Can breast cancer screening be better tailored to a person’s individual risk of cancer? Guidelines advise heightened surveillance in certain women, including those […]
January 24, 2025
TOPLINE: Adjuvant combination leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin (FOLFIRINOX) and other multiagent chemotherapy regimens boost overall survival (OS) in patients with resected pancreatic adenocarcinoma […]
January 23, 2025
The US Food and Drug Administration (FDA) has approved treosulfan (Grafapex, Medexus Pharmaceuticals) in combination with fludarabine as a preparative regimen to clear bone marrow before […]
January 23, 2025
TOPLINE: A recent analysis found that patients with a high genetic risk for rheumatoid arthritis (RA) do not face an increased risk for acute or late […]
January 23, 2025
TOPLINE: Among patients with cancer or autoimmune diseases receiving charitable copay assistance foundation (CPAF) support, 84% reported financial toxicity. Despite having insurance coverage, 41% spent > […]
January 22, 2025
TOPLINE: The analysis of 11,427 Veterans Administration (VA) hospital patients with multiple myeloma (MM) reveals that lymphopenia affects 53% of patients at diagnosis. The median overall […]
January 22, 2025
TOPLINE: A systematic review found that genomic classifier tests can influence risk assessments and treatment decisions among patients with localized prostate cancer but studies evaluating these […]
January 21, 2025
(Reuters) -Atara Biotherapeutics said on Tuesday the U.S. health regulator had placed a clinical hold on its trials for cancer cell therapies, sending the drug developer’s […]
January 21, 2025
TOPLINE: Compared with chemotherapy alone, the addition of radiation to chemotherapy did not improve overall or recurrence-free survival in patients with locally advanced endometrial cancer, a […]